ABOUT BLOCK PAIN RECEPTORS WITH PROLEVIATE

The activation of CB1 and CB2 inhibits the development of intracellular cAMP, therefore resulting in an incredible reduction of your excitatory effect within the neurons [88,89]. Also, the activation of CB2 can more reduce the mast mobile degranulation and the release of professional-inflammatory mediators, building the reduction in pain sensation